Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, announced today the opening of its cutting-edge Center of Excellence for Biologics ...
Two large philanthropic efforts announced this month are expected to boost healthcare research and education at North Carolina State University, the University of North Carolina at Chapel Hill and the ...
The small team at Raleigh-based startup, Collaborations Pharmaceuticals, spends the bulk of its time looking for safe and effective molecules that can be developed into drugs to treat rare and ...
DetraPel, Inc., a clean-tech advanced materials company, will relocate its headquarters and advanced manufacturing operations to Charlotte. The company will invest $3.5 million and bring more than 30 ...
Carolina Liquid Chemistries Corp. of Greensboro has signed a semi-exclusive agreement to distribute a portable chemistry analyzer for the U.S. veterinary market. The company will distribute the ...
North Carolina’s life sciences industry has crossed a milestone – exceeding 100,000 jobs for the first time – and continues to outpace national industry growth and most other top-tier life sciences ...
When Tara Cameron decided she wanted to transition from her career as a certified nursing assistant into a new position in the medical field, she turned to colleagues and friends. Overwhelmingly, they ...
The western flower thrips — an invasive insect that’s not much bigger than a pinhead — takes a huge bite out of agriculture around the world, racking up billions of dollars’ worth of damage on a wide ...
Durham-based 410 Medical has received up to nearly $2 million in U.S. military funding to develop two new versions of LifeFlow, its medical device for treating life-threatening low blood pressure, ...
The North Carolina Biotechnology Center awarded 13 grants and loans totaling $1.4 million to universities and bioscience companies in the second quarter of its 2016-2017 fiscal year ending Dec. 31.
The BRITE program and its partnerships with local universities provided Udemadu with critical hands-on training in cell culture and lab techniques. This provided a strong foundation that made his ...
Fervent Pharmaceuticals of Greenville has finished a Phase 2A clinical trial of FP-101, its new therapy for treating symptoms of menopause including hot flashes and night sweats. “Completing this ...